Keros Therapeutics Inc Revenue per Employee (KROS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Keros Therapeutics Inc   (NASDAQ: KROS)
 

Keros Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 88.77% in the third quarter 2026, year on year to cumulative value of $43 million, Keros Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 552,513. The productivity of Keros Therapeutics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 159 other companies have achieved higher revenue per employee. While Keros Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 243 to 1504. Keros Therapeutics Inc has 78 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KROS Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 88.77 % - -98.76 % -95.97 % 242.91 %
Sales per Employee (TTM) $ 552,513 311,308 544,231 3,304,949 3,422,590
KROS's Total Ranking # 1504 # 243 # 286 # 278 #
Seq. Revenue Change - - 601.82 % -98.18 % 16.66 %

KROS Company Profile >> Back to KROS Efficiency Comparisons >> Compare KROS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 160
Overall Market # 1504

Revenue per Employee Statistics
High Average Low
$ 3,422,590 $ 1,833,301 $ 336,026
(Sep 30 2025)   (Jun 30 2024)



Financial Statements
Keros Therapeutics Inc 's Revenue MRQ $ 40 Millions Visit KROS's Income Statement
Keros Therapeutics Inc 's Revenues TTM $ 43 Millions Visit KROS's aggregate revenue growth
What are KROS's Sales? Visit KROS's Sales by Segment




Other Ratios
Keros Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KROS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KROS's Competitors
Revenue per Employee for KROS's Suppliers
Revenue per Employee for KROS's Customers

You may also want to know
KROS's Sales Growth Rates KROS's Pe Price to earnings ratio KROS's Receivables Turnover Ratio KROS's Stock Quote
KROS's Net Income Growth Rates KROS's Ps Price to Sales ratio KROS's Sales per Employee KROS's Asset Turnover Ratio
KROS's Net Margin KROS's Pb Price to Book ratio KROS's Financial Strength Ratios KROS's Dividend Payout Ratio
Date modified: 2026-11-06T13:02:06+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Alkermes Plc   855,414.15 $ 1,753.599  Million 2,050 
Pfizer Inc  848,333.33 $ 63,625.000  Million 75,000 
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.